[1]王群,杨志刚,许辉东,等.CE和CEF方案辅助化疗对老年乳腺癌患者术后生活质量改善及不良反应的比较[J].疑难病杂志,2015,14(3):304-305,308.
[2]李娇, 张晟, 张瑾.重组人粒细胞集落刺激因子预防乳腺癌化疗后骨髓抑制的疗效分析[J]. 中国癌症杂志, 2014, 24(12):925-930.
[3]Trillet-Lenoir V, Green J, Manegold C, et al. Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy[J]. Eur J Cancer,1993, 29A(3): 319-324.
[4]Smith TJ,Bohlke K,Lyman GH,et al.Recommendations for the Use of WBC Growth Factors:American Society of Clinical Oncology Clinical Practice Guideline Update[J].J Clin Oncol,2015,33(28):3199-3212.
[5]Schnipper LE, Smith TJ, Raghavan D, et al. American society of clinical oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology[J]. J Clin Oncol,2012, 30(14): 1715-1724.
[6]Hollingshead LM,Goa KL.Recombinant granulocyte colony-stimulating factor(rG-CSF).A review of its pharmacological properties and prospective role in neutropenic conditions[J]. Drugs,1991,42(2):300-330.
[7]黄圆圆, 张蓓, 胡丕丽, 等. 滋元灵拮抗吉西他滨所致小鼠骨髓抑制的实验研究[J].中药材, 2010,33(6): 976-979.
[8]张喜平, 张翔, 杨红健, 等. 多种口服升白药物联合粒细胞集落刺激因子治疗化疗相关白细胞减少症的实验研究[J]. 中国中西医结合杂志,2015,35(7): 860-865.
[9]张喜平, 张翔, 杨红健, 等. 多种口服升白药物治疗化疗相关白细胞减少症的实验研究[J]. 中国临床药理学与治疗学,2015,20(3): 246-251.
[10]徐叔云, 卞如濂, 陈修. 药理实验方法学(3版)[M]. 北京: 人民卫生出版社, 2002: 202-203.
[11]吴银萍, 杜景霞, 李艳, 等. 参归软肝胶囊对实验性肝损伤的保护作用研究[J]. 河南科技大学学报(医学版),2011,29(4): 244-246.
[12]Budman DR, Berry DA, Cirrincione CT, et al. Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B[J]. J Natl Cancer Inst,1998, 90(16): 1205-1211.
[13]Vogel CL, Wojtukiewicz MZ, Carroll RR, et al. First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo-controlled phase III study[J]. J Clin Oncol,2005, 23(6): 1178-1184.
[14]Crawford J, Ozer H, Stoller R, et al.Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer[J]. N Engl J Med,1991, 325(3): 164-170.
[15]Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america[J]. Clin Infect Dis,2011, 52(4): e56-e93.
[16]Caselli D, Cesaro S, Arico M. Biosimilars in the management of neutropenia: focus on filgrastim[J]. Biologics,2016, 10(1): 17-22.
[17]Hirbe AC, Uluckan O, Morgan EA, et al. Granulocyte colony-stimulating factor enhances bone tumor growth in mice in an osteoclast-dependent manner[J].Blood,2007, 109(8): 3424-3431.
[18]Lyman GH, Dale DC, Wolff DA, et al. Acute myeloid leukemia or myelodysplastic syndrome in randomized controlled clinical trials of cancer chemotherapy with granulocyte colony-stimulating factor: a systematic review[J]. J Clin Oncol,2010, 28(17): 2914-2924.
[19]霍志刚, 马小莉, 武纪生,等. 康艾注射液治疗化疗后白细胞减少症临床研究[J]. 中医学报, 2017, 32(3):332-335.
[20]许贺娟. 苦参注射液联合化疗治疗乳腺癌术后患者的临床观察[J]. 中医临床研究, 2017, 9(8):120-121.
[21]张永莉. 参附注射液治疗白细胞减少症的观察[J].中国现代药物应用,2010,4(15): 98-99.
[22]刘祥祥, 席亚明, 王丽娜. 参麦注射液治疗肿瘤放化疗后白细胞减少症的Meta分析[J]. 中国循证医学杂志,2014, 14(4): 484-491.
[23]江云丽.黄芪注射液配合生脉注射液治疗肿瘤放化疗后白细胞减少症临床研究[J]. 亚太传统医药, 2016, 12(16):148-149.
[24]徐悦涛, 张虹, 张豪荣,等. 参麦注射液足三里注射联合重组人粒细胞集落刺激因子治疗化疗后白细胞减少症的疗效分析[J]. 中外医疗, 2015(8):177-179.
[25]刘芳, 张红, 谢人明. 珠子参对环磷酰胺所致小鼠白细胞减少的影响[J]. 现代中医药, 2015,35(5): 164-168.
[26]韩慧杰, 朱霞. 重组人粒细胞集落刺激因子治疗化疗后白细胞减少疗效观察[J]. 医药论坛杂志,2011,32(22): 132-133.
[27]贾春芳,段敏,段昕.参芪扶正注射液联合化疗治疗乳腺癌的疗效及对患者造血功能及免疫功能的影响[J].海南医学院学报,2016,22(16):1866-1869.
[28]沈雪梅. 生脉注射液减轻Xelox方案化疗骨髓抑制的临床观察[J]. 中外医学研究, 2017(20):25-26.
[29]张梁.复方苦参注射液预防胃癌术后患者化疗不良反应及对免疫功能的影响[J]. 河北中医, 2016(1):42-45. |